743 related articles for article (PubMed ID: 18255347)
1. Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy.
Kahaleh M; Mishra R; Shami VM; Northup PG; Berg CL; Bashlor P; Jones P; Ellen K; Weiss GR; Brenin CM; Kurth BE; Rich TA; Adams RB; Yeaton P
Clin Gastroenterol Hepatol; 2008 Mar; 6(3):290-7. PubMed ID: 18255347
[TBL] [Abstract][Full Text] [Related]
2. Biliary drainage, photodynamic therapy and chemotherapy for unresectable cholangiocarcinoma with jaundice.
Fuks D; Bartoli E; Delcenserie R; Yzet T; Celice P; Sabbagh C; Chatelain D; Joly JP; Cheron N; Dupas JL; Regimbeau JM
J Gastroenterol Hepatol; 2009 Nov; 24(11):1745-52. PubMed ID: 19780885
[TBL] [Abstract][Full Text] [Related]
3. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy for unresectable cholangiocarcinoma: contribution of single operator cholangioscopy for targeted treatment.
Talreja JP; DeGaetani M; Sauer BG; Kahaleh M
Photochem Photobiol Sci; 2011 Jul; 10(7):1233-8. PubMed ID: 21512706
[TBL] [Abstract][Full Text] [Related]
5. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma.
Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC
J Gastroenterol Hepatol; 2005 Mar; 20(3):415-20. PubMed ID: 15740486
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy for cholangiocarcinoma.
Berr F
Semin Liver Dis; 2004 May; 24(2):177-87. PubMed ID: 15192790
[TBL] [Abstract][Full Text] [Related]
7. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
8. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.
Witzigmann H; Berr F; Ringel U; Caca K; Uhlmann D; Schoppmeyer K; Tannapfel A; Wittekind C; Mossner J; Hauss J; Wiedmann M
Ann Surg; 2006 Aug; 244(2):230-9. PubMed ID: 16858185
[TBL] [Abstract][Full Text] [Related]
9. Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients.
Zeng ZC; Tang ZY; Fan J; Zhou J; Qin LX; Ye SL; Sun HC; Wang BL; Li D; Wang JH; Zeng MS; Guo W; Tan YS
Cancer J; 2006; 12(2):113-22. PubMed ID: 16630402
[TBL] [Abstract][Full Text] [Related]
10. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy.
Zoepf T; Jakobs R; Arnold JC; Apel D; Riemann JF
Am J Gastroenterol; 2005 Nov; 100(11):2426-30. PubMed ID: 16279895
[TBL] [Abstract][Full Text] [Related]
11. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
12. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of slimmer and open-cell-design stents for endoscopic bilateral stenting and endoscopic revision in patients with hilar cholangiocarcinoma (with video).
Kim JY; Kang DH; Kim HW; Choi CW; Kim ID; Hwang JH; Kim DU; Eum JS; Bae YM
Gastrointest Endosc; 2009 Dec; 70(6):1109-15. PubMed ID: 19647244
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study.
Wiedmann M; Caca K; Berr F; Schiefke I; Tannapfel A; Wittekind C; Mössner J; Hauss J; Witzigmann H
Cancer; 2003 Jun; 97(11):2783-90. PubMed ID: 12767091
[TBL] [Abstract][Full Text] [Related]
16. Impact of intraoperative radiotherapy (IORT) on survival of patients with unresectable hilar cholangiocarcinoma.
Kaiser GM; Frühauf NR; Lang H; Sauerwein W; Sotiropoulos GC; Zöpf T; Grabellus F; Wittig A; Oldhafer KJ; Malagó M; Broelsch CE
Hepatogastroenterology; 2008; 55(88):1951-4. PubMed ID: 19260456
[TBL] [Abstract][Full Text] [Related]
17. Palliation for suspected unresectable hilar cholangiocarcinoma.
Connor S; Barron E; Redhead DN; Ireland H; Madhavan KK; Parks RW; Garden OJ
Eur J Surg Oncol; 2007 Apr; 33(3):341-5. PubMed ID: 17175127
[TBL] [Abstract][Full Text] [Related]
18. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study.
Ortner ME; Caca K; Berr F; Liebetruth J; Mansmann U; Huster D; Voderholzer W; Schachschal G; Mössner J; Lochs H
Gastroenterology; 2003 Nov; 125(5):1355-63. PubMed ID: 14598251
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with increased survival after photodynamic therapy for cholangiocarcinoma.
Prasad GA; Wang KK; Baron TH; Buttar NS; Wongkeesong LM; Roberts LR; LeRoy AJ; Lutzke LS; Borkenhagen LS
Clin Gastroenterol Hepatol; 2007 Jun; 5(6):743-8. PubMed ID: 17545000
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy in cholangiocarcinomas.
Ortner MA
Best Pract Res Clin Gastroenterol; 2004 Feb; 18(1):147-54. PubMed ID: 15123089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
